These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17000223)

  • 1. TLR9-based immunotherapy for allergic disease.
    Hayashi T; Raz E
    Am J Med; 2006 Oct; 119(10):897.e1-6. PubMed ID: 17000223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR9-based immunotherapy for the treatment of allergic diseases.
    Farrokhi S; Abbasirad N; Movahed A; Khazaei HA; Pishjoo M; Rezaei N
    Immunotherapy; 2017 Mar; 9(4):339-346. PubMed ID: 28303762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-based approaches to the treatment of allergies.
    Spiegelberg HL; Raz E
    Curr Opin Mol Ther; 2002 Feb; 4(1):64-71. PubMed ID: 11883696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.
    Vollmer J; Krieg AM
    Adv Drug Deliv Rev; 2009 Mar; 61(3):195-204. PubMed ID: 19211030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation: the future cure for allergic diseases.
    Tsitoura DC; Tassios Y
    Ann N Y Acad Sci; 2006 Nov; 1088():100-15. PubMed ID: 17192559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the development of new methods of immunotherapy: potential application of immunostimulatory DNA-conjugated to allergens for treatment of allergic respiratory conditions.
    Creticos PS; Lichtenstein LM
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):304-12; discussion 312-3. PubMed ID: 15119051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undertreatment of allergy: exploring the utility of sublingual immunotherapy.
    Emanuel IA; Parker MJ; Traub O
    Otolaryngol Head Neck Surg; 2009 May; 140(5):615-21. PubMed ID: 19393398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel vaccines and adjuvants for allergen-specific immunotherapy.
    Crameri R; Rhyner C
    Curr Opin Immunol; 2006 Dec; 18(6):761-8. PubMed ID: 17010585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T regulatory cells in allergen-specific immunotherapy.
    Verhagen J; Taylor A; Blaser K; Akdis M; Akdis CA
    Int Rev Immunol; 2005; 24(5-6):533-48. PubMed ID: 16318994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen immunotherapy.
    Huggins JL; Looney RJ
    Am Fam Physician; 2004 Aug; 70(4):689-96. PubMed ID: 15338781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapy.
    Crameri R; Kündig TM; Akdis CA
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):568-73. PubMed ID: 19680120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergy immunotherapy for primary care physicians.
    Stokes JR; Casale TB
    Am J Med; 2006 Oct; 119(10):820-3. PubMed ID: 17000208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in upper airway diseases and allergen immunotherapy in 2007.
    Saltoun C; Avila PC
    J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sublingual immunotherapy--coming of age?].
    Kidon MI; Nelken D
    Harefuah; 2006 Feb; 145(2):123-6, 165. PubMed ID: 16509417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific immunotherapy with allergoids in atopic subjects, hyporeactive to other vaccines.
    Vargiu G; Valcurone G; Agostoni A; Sacchi G; Tassi GC
    Boll Ist Sieroter Milan; 1986; 65(3):230-6. PubMed ID: 3778658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma?
    Jacobsen L; Valovirta E
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):556-60. PubMed ID: 17989534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils.
    Månsson A; Cardell LO
    J Leukoc Biol; 2009 Apr; 85(4):719-27. PubMed ID: 19129482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-based vaccines for allergic disease.
    Spiegelberg HL; Takabayashi K; Beck L; Raz E
    Expert Rev Vaccines; 2002 Aug; 1(2):169-77. PubMed ID: 12901556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.